Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cihan Ay

Showing results (51-60 of 344) with videos related to

Pageof 35
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 19, 2023
Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated reviewCihan Ay, Laurent Frenzel, Karen Pinachyan, et al.
Hamostaseologie|January 8, 2024
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer ImmunotherapiesFlorian Moik, Jakob M Riedl, Cornelia Englisch, et al.
Thrombosis Research|January 21, 2014
Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemiaJohannes Thaler, Ingrid Pabinger, Wolfgang R Sperr, et al.
Thrombosis Research|September 29, 2014
Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one yearJohannes Thaler, Renate Koppensteiner, Ingrid Pabinger, et al.
Thrombosis Research|July 27, 2015
Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulantsFlorian Posch, Oliver Königsbrügge, Christoph Zielinski, et al.
Annals of Hematology|March 2, 2011
Thrombin generation in patients with a bleeding tendency of unknown originCihan Ay, Johanna Haselböck, Clarissa Laczkovics, et al.
European Journal of Internal Medicine|March 12, 2021
Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillationStephan Nopp, Oliver Königsbrügge, Daniel Kraemmer, et al.
Kidney International Reports|January 15, 2025
A Systematic Review of Safety and Efficacy of Factor XI/XIa Inhibitors in Patients With ESKD on HemodialysisDaniel Steiner, Daniel Kraemmer, Stephan Nopp, et al.
Research and Practice in Thrombosis and Haemostasis|October 12, 2020
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysisStephan Nopp, Florian Moik, Bernd Jilma, et al.
Clinical and Experimental Medicine|February 9, 2018
Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillationOliver Königsbrügge, Günter Weigel, Peter Quehenberger, et al.
Pageof 35

Showing results (51-60 of 344) with videos related to

Sort By:
Pageof 35
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 19, 2023
Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated reviewCihan Ay, Laurent Frenzel, Karen Pinachyan, et al.
Hamostaseologie|January 8, 2024
Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer ImmunotherapiesFlorian Moik, Jakob M Riedl, Cornelia Englisch, et al.
Thrombosis Research|January 21, 2014
Clinical evidence for a link between microparticle-associated tissue factor activity and overt disseminated intravascular coagulation in patients with acute myelocytic leukemiaJohannes Thaler, Ingrid Pabinger, Wolfgang R Sperr, et al.
Thrombosis Research|September 29, 2014
Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one yearJohannes Thaler, Renate Koppensteiner, Ingrid Pabinger, et al.
Thrombosis Research|July 27, 2015
Treatment of venous thromboembolism in patients with cancer: A network meta-analysis comparing efficacy and safety of anticoagulantsFlorian Posch, Oliver Königsbrügge, Christoph Zielinski, et al.
Annals of Hematology|March 2, 2011
Thrombin generation in patients with a bleeding tendency of unknown originCihan Ay, Johanna Haselböck, Clarissa Laczkovics, et al.
European Journal of Internal Medicine|March 12, 2021
Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillationStephan Nopp, Oliver Königsbrügge, Daniel Kraemmer, et al.
Kidney International Reports|January 15, 2025
A Systematic Review of Safety and Efficacy of Factor XI/XIa Inhibitors in Patients With ESKD on HemodialysisDaniel Steiner, Daniel Kraemmer, Stephan Nopp, et al.
Research and Practice in Thrombosis and Haemostasis|October 12, 2020
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysisStephan Nopp, Florian Moik, Bernd Jilma, et al.
Clinical and Experimental Medicine|February 9, 2018
Plasma clot formation and clot lysis to compare effects of different anticoagulation treatments on hemostasis in patients with atrial fibrillationOliver Königsbrügge, Günter Weigel, Peter Quehenberger, et al.
Pageof 35